Rockwell Medical, Inc.
RMTI
$0.69
$0.033.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.61M | -554.00K | -1.75M | -1.49M | -1.52M |
| Total Depreciation and Amortization | 511.00K | 546.00K | 544.00K | 563.00K | 539.00K |
| Total Amortization of Deferred Charges | 88.00K | 89.00K | 89.00K | 88.00K | 88.00K |
| Total Other Non-Cash Items | 1.05M | 779.00K | 910.00K | 894.00K | 1.14M |
| Change in Net Operating Assets | -210.00K | 1.43M | -1.10M | 1.79M | -3.74M |
| Cash from Operations | -167.00K | 2.29M | -1.31M | 1.84M | -3.49M |
| Capital Expenditure | -425.00K | -86.00K | -229.00K | -164.00K | -63.00K |
| Sale of Property, Plant, and Equipment | 175.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 128.00K | -4.05M | -4.08M | 61.00K | 62.00K |
| Cash from Investing | -122.00K | -4.13M | -4.31M | -103.00K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -313.00K | -309.00K | -322.00K | -215.00K | -347.00K |
| Issuance of Common Stock | -- | 0.00 | 7.82M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -500.00K | -750.00K | -750.00K | -435.00K | -436.00K |
| Cash from Financing | -813.00K | -1.06M | 6.74M | -650.00K | -783.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.10M | -2.90M | 1.13M | 1.09M | -4.27M |